Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Immunocore impresses with $75m series C

Jan 18, 2021 • Edison Fu

The Eli Lilly and Wuxi AppTec-backed oncology drug developer has raised the money from new and existing backers, and will use the cash to boost its product pipeline.

Immunocore, a UK-based immunotherapy developer backed by pharmaceutical firms Eli Lilly and WuXi AppTec, has secured $75m in a series C round led by an unnamed returning investor.

The round included accounts and vehicles for investment management firm BlackRock as well as undisclosed existing backers. In addition, Oxford Finance supplied $100m in debt financing.

Founded in 2008 by immunotherapy provider MediGene, Immunocore is working on T-cell receptor (TCR)-based drugs, which introduce modified white blood cells in the immune system in…

Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Events
GCV Institute: CVC Investment Programs
Dec 3 -
Dec 4, 2024
Online
Events
GCV Connect: Korea 2024
Dec 10 -
Dec 12, 2024
Seoul (South Korea)
Events
GCV Institute: CVC Investment Programs
Jan 28 -
Jan 29, 2025
Online
Events
GCV Institute: CVC Investment Programs
Mar 17 -
Mar 18, 2025
Palo Alto, CA (USA)
Events
GCVI Summit 2025
Mar 18 -
Mar 20, 2025
Monterey, CA (USA)
Events
GCV Institute: Landing the Value of Corporate Venturing
May 1 -
May 6, 2025
Online
Events
GCV Symposium 2025
Jun 17 -
Jun 19, 2025
London (UK)
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here